Clinica Baviera S.A (CBAV) | Stock Overview & Key Data

Clinica Baviera S.A. | Mid-cap | Healthcare

€39.40

2.07%

| Clinica Baviera S.A Stock Comparison:

Clinica Baviera S.A vs EuroEspes S.A Clinica Baviera S.A vs Banco de Sabadell Clinica Baviera S.A vs Amadeus IT Clinica Baviera S.A vs Laboratorios Clinica Baviera S.A vs Faes Farma S.A Clinica Baviera S.A vs IBEX 35 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Clinica Baviera S.A Performance Comparison

Loading chart data...

Clinica Baviera S.A

IBEX 35

View Full Price History

Stock Range

Today's Range

Low: €38.10 High: €39.50

on June 17, 2025

52 Week Range

Low: €26.40 High: €43.60

on June 28, 2024

on June 9, 2025

All-Time High: €43.60 on June 9, 2025

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €617.3M

EPS i 2.47

P/E Ratio (TTM) i 15.63

Forward P/E i 21.93

P/B Ratio i 5.60

PEG Ratio i 21.93

Div. Yield i 4.07%

ROE i 38.50%

Beta i 0.802

Debt to Equity i 54.87

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 22.93%

Profit Margin i 14.55%

Returns and Earnings

Return on Assets (TTM) i 16.84%

Return on Equity (TTM) i 38.50%

EBITDA i €78.1M

Net Income (TTM) i €40.7M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i €6.28

Estimated Dividend Yield i 16.27%

5 Year Average Dividend Yield i 3.79%

Last 12-Month Dividend Yield i 4.07%

Last 12-Month Dividend i €1.57

% of Earnings Paid as Dividends i 63.56%

Dividend Date i N/A

Ex-Dividend Date i June 11, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Clinica Baviera S.A CBAV	617.34M Mid-cap	-8.37%	3.14%	10.99%	21.98%	25.08%	38.85%	90.15%	291.88%
EuroEspes S.A EEP	6.26M Small	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.89%	12.50%
Banco de Sabadell SAB	14.52B Large-cap	1.07%	4.03%	4.03%	46.39%	52.69%	59.77%	247.50%	742.42%
Amadeus IT AMS	30.83B Large-cap	-3.45%	-0.25%	1.23%	6.24%	5.19%	10.06%	34.59%	40.37%
Laboratorios ROVI	2.86B Large-cap	0.54%	6.45%	6.95%	-10.94%	-12.27%	-35.71%	-1.24%	132.50%
Faes Farma S.A FAE	1.41B Large-cap	4.93%	4.93%	35.45%	26.63%	27.35%	21.45%	20.80%	19.21%

Ownership & Short Interest

Insider Ownership i 84.88%

Institutional Ownership i 4.06%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 13K

Average 90-Day Volume i 10K

Clinica Baviera S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Clinica Baviera S.A would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is CBAV's 52-week high and low?

In the last 52 weeks, Clinica Baviera S.A reached a high of €43.60 (on June 9, 2025) and a low of €26.40 (on June 28, 2024).

What is the market cap and P/E ratio for CBAV?

Curious about Clinica Baviera S.A's size and valuation? Its market capitalization stands at 617.34M. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.63, and the forward P/E (looking ahead) is 21.93.

Does CBAV pay dividends? If so, what's the yield?

Yes, Clinica Baviera S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 4.07%, and the company is expected to pay out €6.28 per share over the coming year.

Who are Clinica Baviera S.A's main competitors or similar companies to consider before investing?

When looking at Clinica Baviera S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
EuroEspes S.A EEP	6.26M	Healthcare	Diagnostics & Research	0.00%	1.89%
Banco de Sabadell SAB	14.52B	Healthcare	Diagnostics & Research	59.77%	247.50%
Amadeus IT AMS	30.83B	Healthcare	Medical Care Facilities	10.06%	34.59%
Laboratorios ROVI	2.86B	Healthcare	Drug Manufacturers - Specialty & Generic	-35.71%	-1.24%
Faes Farma S.A FAE	1.41B	Healthcare	Drug Manufacturers - Specialty & Generic	21.45%	20.80%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Clinica Baviera S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Clinica Baviera S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 38.50%, the Debt to Equity ratio from the most recent quarter is 54.87, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for CBAV?

Looking at Clinica Baviera S.A's growth, its revenue over the trailing twelve months (TTM) was €280M. Compared to the same quarter last year (YoY), quarterly revenue grew by 20.80%, and quarterly earnings saw a YoY growth of 3.70%.

How much of CBAV stock is held by insiders and institutions?

Wondering who owns Clinica Baviera S.A stock? Company insiders (like executives and directors) hold about 84.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.06%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.